Original Articles
Copyright ©The Author(s) 2001. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Feb 15, 2001; 7(1): 60-65
Published online Feb 15, 2001. doi: 10.3748/wjg.v7.i1.60
Inhibitory effects of RRR-α-tocopheryl succinate on benzo(a)pyrene (B(a)P)-induced forestomach carcinogenesis in female mice
Kun Wu, Yu Juan Shan, Yan Zhao, Jian Wu Yu, Bai He Liu
Kun Wu, Yu Juan Shan, Yan Zhao, Bai He Liu, Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin 150001, Heilongjiang Province, China
Jian Wu Yu, The Second Affiliated Hospital, Harbin Medical University, Harbin 150001, Heilongjiang Province, China
Kun Wu, Professor, engaged in the study on anti-carcinogenetic nutrients in food, having more than 40 papers published.
Author contributions: All authors contributed equally to the work.
Supported by National Natural Science Foundation of China, No.39870662
Correspondence to: Prof. Kun Wu, Department of Nutrition and Food Hygiene, School of Public Health, Harbin Medical University, Harbin 150001, Heilongjiang Province, China. wukun@public.hr.hl.cn
Telephone: 0086-451-3648665 Fax: 0086-451-3648665
Received: July 17, 2000
Revised: October 21, 2000
Accepted: October 28, 2000
Published online: February 15, 2001
Abstract

AIM: To study the inhibitory effects of VES (RRR-α-tocopheryl Succinate, VES), a derivative of natural Vitamin E, on benzo(a)pyrene(B(a)P)-induced forestomach tumor in female mice.

METHODS: The model of B(a)P-induced forestomach tumor was established according to the methods of Wattenberg with slight modifications. One hundred and eighty female mice (6 weeks old) were divided into six groups equally; negative control (Succinic acid), vehicle control (Succinate + B(a)P),positive control(B(a)P), high VES(2.5 g/kg.b.w+B(a)P), low VES (1.25 g/kg.b.w + B(a)P) ig as well as VES by ip (20 mg/kg.b.w + B(a)P). Except the negative control group, the mice were administrated with B(a)P ig. and corresponding treatments for 4 weeks to study the anti-carcinogenetic effect of VES during the initiation period. The experiment lasted 29 weeks, in which the inhibitory effects of VES both on tumor incidence and tumor size were tested.

RESULTS: The models of B(a)P-induced forestomach tumor in female mice were established successfully. Some were cauliflower-like, others looked like papilla, even a few were formed into the ulcer cavities. VES at 1.25 g/kg.b.w, 2.5 g/kg.b.w. by ig and 20 mg/kg.b.w. via ip could decrease the number of tumors per mouse (1.7 ± 0.41, 1.60 ± 0.34 and 1.1 ± 0.43), being lower than that of B(a)P group (5.4 ± 0.32, P < 0.05). The tumor incidence was inhibited by 18.2%, 23.1% and 50.0%. VES at 1.25 g/kg.b.w., 2.5 g/kg.b.w. by ig and 20 mg/kg.b.w. via ip reduced the total volume of tumors per mouse (54.8 ± 8.84, 28.4 ± 8.32 and 23.9 ± 16.05), being significantly lower than that of B(a)P group (150.2 ± 20.93, P < 0.01). The inhibitory rates were 63.5%, 81.1% and 84.1%, respectively.

CONCLUSION: VES has inhibitory effects on B(a)P-induced forestomach carcinogenesis in female mice, especially by ip and it may be a potential anti-cancer agent in vivo.

Keywords: stomach neoplasms, antineoplastic agents, vitamin E, transforming growth factors, apoptosis, benzo(a)pyrene